It’s been more than 2,000 years since Jerusalem made a mark with technology.
Teva Pharmaceutical Industries Ltd. will buy back as much as $1 billion in shares and American depositary receipts over the next 12 months.
Teva Pharmaceutical Industries Ltd. is ready for an acquisition the size of last year’s 3.63 billion-euro ($4.9 billion) Ratiopharm GmbH takeover as it aims to boost sales to $31 billion by 2015.
Cephalon Inc. won an appeals court ruling that could help it block generic versions of the muscle- relaxant Amrix.
Teva Pharmaceutical Industries Ltd. investors may have to brace for more profit disappointments as threats loom over its top drug.
Teva Pharmaceutical Industries Ltd. , the world’s largest maker of generic drugs, said it got a $1.5 billion credit line to refinance debt at more favorable terms.
A Motorola Inc. unit sued Apple Inc. , alleging the maker of the iPad computer tablet and iPhone mobile phone, is infringing six of its patents.
Amgen Inc. won a U.S. court ruling that bars Teva Pharmaceutical Industries Ltd. from selling a generic version of the kidney drug Sensipar until at least 2016.
Merck & Co. ’s Schering-Plough unit won an appeals court ruling that revives its effort to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013.
ITT Corp ., a military electronics supplier, said it reached a settlement of patent-infringement claims it filed against Motorola Inc. over assisted-global position system technology.
"Teva has suffered staggering losses as a result of its purchase of CDO auction-rate notes and other auction-rate securities structured and underwritten by Merrill."
- Petah Tikva on Aug 07, 2009